Trial Profile
A Multicenter Randomized Double-Blind Study to Compare the Efficacy, Safety, and Tolerability of Rabeprazole ER 50 mg With Placebo in Subjects With Symptomatic Gastroesophageal Reflux Disease (sGERD).
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 15 Feb 2016
Price :
$35
*
At a glance
- Drugs Rabeprazole (Primary)
- Indications Gastro-oesophageal reflux
- Focus Therapeutic Use
- Sponsors Eisai Inc; Eisai Medical Research
- 17 Jun 2009 New trial record